Publication | Closed Access
Development of two synthetic routes to CE-178,253, a CB1 antagonist for the treatment of obesity
24
Citations
17
References
2008
Year
Metabolic SyndromeBiochemistryFunctional SelectivityMedicineMechanism Of ActionPharmacological AgentCb1 AntagonistPharmacotherapySynthetic RoutesPharmacologyDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1